Rate Control in Atrial Fibrillation

Rapid Ventricular Response Atrial Fibrillation Clinical Trial

Official title: Oral Propranolol, Diltiazem, Metoprolol and Verapamil in Atrial Fibrillation Rate Control in Patients With Stable Hemodynamic Status

Status Completed

Clinical Trial Summary

Rate control in atrial fibrillation is a usual battle in emergency departments. Oral medications have a natural superiority to intravenous ones because they are easy-to-use and decrease the workload in busy emergency departments.

This study wants to find an effective oral medication for rate control in rapid ventricular response atrial fibrillation. Propranolol and Metoprolol, Diltiazem and Verapamil are compared in patients with a stable hemodynamic status.

Clinical Trial Description

n/a

Study Design

Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Caregiver), Primary Purpose: Treatment

Related Conditions & MeSH terms

• Atrial Fibrillation
• Rapid Ventricular Response Atrial Fibrillation

• NCT number: NCT01655303
• Study type: Interventional
• Source: Tehran University of Medical Sciences
• Status: Completed
• Phase: Phase 4
• Start date: February 2011
• Completion date: December 2011